High-Dose Iodine I 131 Metaiodobenzylguanidine, Topotecan, and Peripheral Stem Cell Transplant in Treating Young Patients With Relapsed Stage 4 Neuroblastoma or Primary Resistant High-Risk Neuroblastoma
This study has been withdrawn prior to enrollment.
(Withdrawn because protocol has been discontinued. It was never opened.)
Children's Cancer and Leukaemia Group
Information provided by:
National Cancer Institute (NCI)
First received: October 18, 2006
Last updated: July 9, 2013
Last verified: June 2007
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
|Study Status:||This study has been withdrawn prior to enrollment.|
|Study Completion Date:||No date given|
|Estimated Primary Completion Date:||July 2008 (Final data collection date for primary outcome measure)|